Krispy Kreme Inc vs Medpace Holdings Inc — how do they compare? Krispy Kreme Inc trades at $3.34 (market cap $574.09M), while Medpace Holdings Inc trades at $536.29 (market cap $15.31B). The key difference: Medpace Holdings Inc is far larger — about 26.7× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays a 3.47% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| DNUT | MEDP | |
|---|---|---|
Market Cap | $574.09M | $15.31B |
Sector | Consumer Staples | Technology |
52-Week High | $4.70 | $620.59 |
52-Week Low | $2.92 | $308.88 |
Enterprise Value | $1.77B | $14.78B |
Dividend Yield | 3.47% | — |
Signals from Pluang's Aura AI — not financial advice
Krispy Kreme (DNUT) trades at $3.47, up 0.87% today, with a bearish technical signal and mixed earnings history. The company reported a net loss of $515.77M in 2025 despite a gross margin of 75.56%, while analyst consensus leans bullish with 50% buy ratings. Recent news highlights strategic pivots to capital-light models and seasonal product launches to drive engagement.
Outlook remains challenged by persistent losses and high debt, but positive free cash flow in Q1 2026 and international growth potential offer catalysts. Key risks include execution on turnaround plans and competitive pressures in the consumer staples sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →